Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Transmission Dynamics of Carbapenemase Genes in CREC, Guangd
2026-07-03
This study provides a detailed genomic and epidemiological characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the COVID-19 pandemic. The findings reveal high rates of multidrug resistance, predominant plasmid-borne blaNDM-1, and efficient horizontal gene transfer, underscoring the need for vigilant surveillance and resistance modeling.
-
Pam3CSK4 TFA: Precision TLR1/2 Agonist for Immune Profiling
2026-07-03
Pam3CSK4 TFA from APExBIO empowers researchers to dissect TLR1/2-driven immune responses with unprecedented fidelity, enabling translational breakthroughs in maternal-neonatal immunity and inflammatory disease modeling. Learn how to optimize experimental design, troubleshoot cytokine profiling, and leverage recent biomarker discoveries for actionable results.
-
Applied Insights: Alcian Blue & Nuclear Fast Red Staining Ki
2026-07-02
Unlock streamlined, reproducible detection of mucopolysaccharides and chondrogenic differentiation with the Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5. This dual-stain solution empowers advanced histology workflows, offering clarity in small tissue biopsies and optimized troubleshooting for stem cell and tissue research.
-
HyperScribe™ Poly (A) Tailing Kit: Engineering mRNA for Prec
2026-07-02
Explore the HyperScribe™ Poly (A) Tailing Kit for advanced mRNA stability enhancement and translation efficiency improvement. This article uniquely examines how precise enzymatic polyadenylation transforms in vitro RNA for next-generation therapeutic and research applications.
-
Hexa-acylated LPS from Gut Microbiota Boosts Cancer Immunoth
2026-07-01
This study identifies a specific structural variant of gut microbiota-derived lipopolysaccharides—hexa-acylated LPS—as a functional enhancer of anti-PD-1 immunotherapy efficacy. By dissecting metagenomic and experimental evidence, the research clarifies how LPS structure, rather than only bacterial taxonomy, shapes antitumor immune responses, offering new directions for microbiome-informed cancer therapy.
-
EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage
2026-07-01
This study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly amplify the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT) by boosting DNA double-strand break formation and modulating the immune microenvironment. The findings suggest a promising strategy to sensitize tumors to FLASH-RT and improve therapeutic outcomes in cancer treatment.
-
Filipin III in Cholesterol Homeostasis: Beyond Visualization
2026-06-30
Explore how Filipin III, a polyene macrolide antibiotic, advances cholesterol detection in membranes and unlocks new mechanistic insights for metabolic disease research. Dive into protocol nuances, novel findings, and practical assay optimization in this comprehensive guide.
-
Tubastatin A: Precision HDAC6 Inhibition for Translational R
2026-06-30
Tubastatin A empowers researchers with highly selective HDAC6 inhibition, enabling confident dissection of cell death and inflammation pathways in cancer and cardiac injury models. Recent evidence illustrates its capacity to suppress pyroptosis and necroptosis, translating to robust myocardial protection and workflow reproducibility.
-
A Surrogate BBB Model for High-Throughput CNS Drug Screening
2026-06-29
This study introduces a high-throughput in vitro blood-brain barrier (BBB) model that integrates LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction to predict CNS drug permeability. The model demonstrates strong correlation with in vivo brain distribution, addressing key limitations of past approaches and enabling more efficient early-stage CNS drug discovery.
-
Hoechst 33342: Enabling Mechanistic Discovery in Cell Signal
2026-06-29
This thought-leadership article explores how Hoechst 33342, a bis-benzimidazole fluorescent dye from APExBIO, powers precision nuclear imaging in translational research. We bridge recent mechanistic insights—such as endothelial-smooth muscle crosstalk in hypoxia pulmonary hypertension—with strategic guidance for workflow optimization, experimental rigor, and translational relevance. Contextual protocol recommendations and critical evidence links position this piece beyond standard product guides, offering actionable perspectives for researchers at the cutting edge of cell biology.
-
rTMS Enhances Amyloid Clearance via GABAergic Modulation in
2026-06-28
This study reveals that repetitive transcranial magnetic stimulation (rTMS) promotes cognitive recovery in Alzheimer’s disease by activating GABAergic neurons and upregulating the Cx3cl1-Cx3cr1 axis, thereby enhancing microglial phagocytosis and reducing amyloid plaque burden. These findings provide a mechanistic foundation for non-invasive therapeutic strategies targeting neuroimmune interactions in AD.
-
Moxidectin Boosts Nystatin Synergy Against Oral Candidiasis
2026-06-27
This study demonstrates that moxidectin, an antiparasitic agent, enhances ergosterol biosynthesis in Candida albicans, thereby synergizing with polyene antifungals such as nystatin to improve efficacy against oral candidiasis. The findings open new strategies for overcoming antifungal resistance and optimizing treatment protocols in clinical and research settings.
-
AS1842856 Foxo1 Inhibitor: Protocols for Metabolic Pathway R
2026-06-26
AS1842856 enables precise, high-specificity inhibition of Foxo1, unlocking robust experimental control over gluconeogenesis and autophagy pathways. This article details best-practice workflows, troubleshooting tips, and advanced applications, including how recent epigenetic insights inform stem cell and metabolic disease research.
-
Miltefosine: Dual-Pathway Modulator for Leukopenia and Oncol
2026-06-26
Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) uniquely bridges PI3K/Akt inhibition and Ras/MEK/ERK activation, enabling advanced workflows in both cancer and leukopenia research. This dual mechanism unlocks new experimental strategies for restoring immune function and limiting tumor progression.
-
Veratridine: Advanced Protocols for Sodium Channel Dynamics
2026-06-25
Explore the scientific foundation and optimized protocols for using Veratridine as a voltage-gated sodium channel opener in sodium channel dynamics research. This article delivers practical insights, integrating mechanistic depth and the latest stem cell assay advances.